AbbVie Faces House Subpoena Over Humira Pricing
The chairwoman of the U.S. House Committee on Oversight and Government Reform on Tuesday announced her intention to subpoena AbbVie Inc. for documents related to the committee's investigation into how big-name...To view the full article, register now.
Already a subscriber? Click here to view full article